pe
pep-05266 v1 CC-BY-SA-4.0

SPAG11A cancer-fighting peptide

A peptide studied for its ability to fight cancer cells; experimental, not yet an approved drug.

statusbioassayed targetANTICANCER length52 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.648
avg pLDDT73.4
ranking score0.717
STRUCTURE · PEP-05266 × ANTICANCER
ranking0.717
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence52 aa
1510152025303540455052
PGDIPPGIRNTVC LMQQGHCRLFMCR SGERKGDICSDPW NRCCVPYSVKDRR
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.7167757749557495 boltz-2
3-letter notation
Pro-Gly-Asp-Ile-Pro-Pro-Gly-Ile-Arg-Asn-Thr-Val-Cys-Leu-Met-Gln-Gln-Gly-His-Cys-Arg-Leu-Phe-Met-Cys-Arg-Ser-Gly-Glu-Arg-Lys-Gly-Asp-Ile-Cys-Ser-Asp-Pro-Trp-Asn-Arg-Cys-Cys-Val-Pro-Tyr-Ser-Val-Lys-Asp-Arg-Arg
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). SPAG11A cancer-fighting peptide (pep-05266, v1). PeptideModel. https://peptidemodel.com/card/pep-05266
@peptide{pep05266,
  sequence = {PGDIPPGIRNTVCLMQQGHCRLFMCRSGERKGDICSDPWNRCCVPYSVKDRR},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use